Hemostemix Appoints the Honourable Sheila Copps, OC, PC, to Board of Advisors and Ratifies Thomas Smeenk as Chief Executive Officer
Calgary, Alberta--(Newsfile Corp. - April 7, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of the Honorable Sheila Copps, OC, PC, to its Board of Advisors. Sheila was the Deputy Prime Minister of Canada, Minister of Environment, Minister of Heritage and a senior member of the federal cabinet for 10 years. From her work on diversity and inclusion, to protection of the environment, to support for young Canadians and...
2020-04-07 9:15 AM EDT
Hemostemix Announces Closing of Second Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - March 26, 2020) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSXV: HEM) (OTC: HMTXF) announces it has closed the second tranche of its previously announced non-brokered private placement of units ("Units") for gross proceeds of up to $3,000,000 (the "Offering"). The second tranche of the Offering consisted of the issuance of an aggregate of 17,750,000 Units at a price of $0.01 per Unit for gross proceeds of $177,500. Each Unit consists of one common...
2020-03-26 8:00 PM EDT
Hemostemix Announces Peter Lacey as Chairman of the Board of Directors
Calgary, Alberta--(Newsfile Corp. - March 19, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the election of Mr. Peter Lacey, ICD.D as Chairman of its Board of Directors. Peter Lacey is currently the Chairman of Cervus Equipment Corporation (CERV.TO), a company he and his partners started in 1999 and built from five John Deere dealerships into a company that owns 63 dealerships selling six brands in three countries with revenues of $1.1...
2020-03-19 9:00 AM EDT
Hemostemix Announces Dr. York Hsiang Joins Its Scientific Advisory Board
Calgary, Alberta--(Newsfile Corp. - March 16, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of York N. Hsiang, MB. ChB, MHSc, FRCSC, Professor of Vascular Surgery at the University of British Columbia, and Consultant Surgeon at the Vancouver General Hospital, to its Scientific Advisory Board ("SAB"). Born in Taiwan, educated in the United States, New Zealand, and Canada, Dr. Hsiang has diverse interests in vascular...
2020-03-16 9:00 AM EDT
Hemostemix Announces Corporate Update
Calgary, Alberta--(Newsfile Corp. - March 10, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has paid $2,330,633.84 to counsel for J.M. Wood Investments Ltd,("JM Wood") in full satisfaction of the Court of Queen's Bench of Alberta Order dated February 28, 2020. JM Wood's application for the appointment of a receiver is now dismissed. Pursuant to the Order, the Company paid into trust with counsel for JM Wood, on March 9, 2020, the...
2020-03-10 9:09 PM EDT
Hemostemix Announces Closing of First Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - March 5, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed the initial tranche of its previously announced non-brokered private placement of units ("Units") for gross proceeds of up to $3,000,000 (the "Offering"). The first tranche of the Offering consisted of the issuance of an aggregate of 254,620,442 Units at a price of $0.01 per Unit for gross proceeds of $2,546,204.42. Each Unit consists of one...
2020-03-05 4:05 PM EST
IIROC Trade Resumption - Hemostemix Inc.
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2017) - Trading resumes in: Company: Hemostemix Inc.
2017-02-09 4:11 PM EST
IIROC Trade Halt - Hemostemix Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2017) - The following issues have been halted by IIROC: Company:
2017-01-06 1:08 PM EST